Bank Pictet & Cie (Europe)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.9M Sell
44,977
-6,663
-13% -$6.81M 1.05% 26
2026
Q1
$47.5M Sell
51,640
-8,232
-14% -$8.35M 1.01% 29
2025
Q4
$64.3M Sell
59,872
-8,323
-12% -$7.96M 1.28% 20
2025
Q3
$52M Sell
68,195
-1,334
-2% -$993K 1.04% 30
2025
Q2
$54.2M Buy
69,529
+2,597
+4% +$2.02M 1.16% 25
2025
Q1
$55.3M Buy
66,932
+2,174
+3% +$1.81M 1.32% 22
2024
Q4
$50M Buy
64,758
+2,568
+4% +$2.13M 1.1% 25
2024
Q3
$55.1M Buy
62,190
+705
+1% +$634K 1.3% 22
2024
Q2
$55.7M Sell
61,485
-12,219
-17% -$9.77M 1.36% 22
2024
Q1
$57.3M Buy
73,704
+15,687
+27% +$11.2M 1.49% 21
2023
Q4
$33.8M Buy
58,017
+4,070
+8% +$2.38M 1% 25
2023
Q3
$29M Sell
53,947
-136
-0.3% -$70.1K 1.01% 24
2023
Q2
$25.4M Buy
54,083
+876
+2% +$367K 0.86% 34
2023
Q1
$18.3M Buy
53,207
+50,269
+1,711% +$17M 0.76% 39
2022
Q4
$1.07M Sell
2,938
-895
-23% -$317K 0.05% 99
2022
Q3
$1.24M Sell
3,833
-14
-0.4% -$4.44K 0.06% 97
2022
Q2
$1.25M Sell
3,847
-804
-17% -$241K 0.06% 93
2022
Q1
$1.33M Buy
4,651
+218
+5% +$56.1K 0.05% 97
2021
Q4
$1.22M Buy
4,433
+1,986
+81% +$503K 0.04% 103
2021
Q3
$565K Sell
2,447
-117
-5% -$28.9K 0.02% 127
2021
Q2
$588K Buy
2,564
+564
+28% +$113K 0.02% 128
2021
Q1
$374K Hold
2,000
0.02% 136
2020
Q4
$338K Buy
+2,000
New +$299K 0.02% 126
2018
Q4
Sell
-2,075
Closed -$223K 150
2018
Q3
$223K Sell
2,075
-87,520
-98% -$8.75M 0.03% 154
2018
Q2
$7.64M Buy
89,595
+6,740
+8% +$554K 1.18% 25
2018
Q1
$6.41M Buy
82,855
+11,078
+15% +$892K 1.06% 33
2017
Q4
$6.06M Buy
71,777
+1,800
+3% +$153K 0.86% 39
2017
Q3
$5.99M Buy
69,977
+16,827
+32% +$1.38M 0.86% 37
2017
Q2
$4.37M Buy
53,150
+2,465
+5% +$201K 0.62% 43
2017
Q1
$4.26M Buy
50,685
+37,150
+274% +$2.98M 0.61% 47
2016
Q4
$995K Buy
+13,535
New +$1.01M 0.17% 76

Other funds holding LLY

Bank Pictet & Cie (Europe)'s LLY Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $6.81M and leaving 44,977 shares worth $53.9M. The position accounts for 1.05% of the portfolio, ranked #26.

Bank Pictet & Cie (Europe) first reported a position in LLY in Q4 2016 and has held it in 31 quarters since. The position peaked at $64.3M in Q4 2025. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Bank Pictet & Cie (Europe) held 44,977 shares of Eli Lilly worth $53.9M as of Q2 2026.
  • Bank Pictet & Cie (Europe) sold 6,663 Eli Lilly shares in Q2 2026, an estimated $6.81M.
  • Eli Lilly made up 1.05% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #26 holding.
  • Bank Pictet & Cie (Europe) first reported a position in Eli Lilly in Q4 2016 and has held it in 31 quarters since.
  • Bank Pictet & Cie (Europe)'s Eli Lilly position peaked at $64.3M in Q4 2025.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.